Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Oncology Dominant As Japan Maintains Approvals Pace

Several Global Firsts In Annual Tally

Jun 23 2020

• By Ian Haydock

Shibuya, Tokyo, Japan crosswalk and cityscape. - Image — Japan Maintains Approvals Pace In Fiscal 2019 • Source: Shutterstock

Related Content

US FDA Ends 2019 With Second-Highest Approval Count After Second-Half Rebound

Jan 02 2020

US FDA Says Data Integrity Remains Challenging For API Manufacturers

Dec 04 2019

New Japan PMDA Head Brings Strong Clinical, Patient Focus To Role

Jun 21 2019

Japan’s Conditional Approval System Passes Test With Global First Lorlatinib Nod

Oct 24 2018

Japanese OK In COPD Gives AstraZeneca’s Breztri Aerosphere First Regulatory Approval

Jun 19 2019

AML Contender Quizartinib Gains First Approval, In Japan

Jun 20 2019

Related Companies

Ono Pharmaceutical Company, Ltd.

Daiichi Sankyo Co., Ltd.

Chugai Pharmaceutical Co., Ltd.

AstraZeneca PLC

Merck KGaA

Nippon Shinyaku Co., Ltd.

Roche Holding AG

Additional Topics

Japan Asia Pacific Approvals Regulation Cancer BioPharmaceutical

More from Japan

More from Asia

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window